DEVELOPMENT OF PAH ON LONG-TERM PERTUZUMAB/TRASTUZUMAB THERAPY FOR BREAST CANCER

被引：0
|
作者：
Sethi, Japandeep
Christiansen, David
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.3895
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：6042A / 6043A
页数：2
相关论文
共 50 条
  • [1] Impressive Long-term Response with Pertuzumab and Trastuzumab in HER2-positive Breast Cancer with Brain Metastasis
    Russillo, Michelangelo
    Ferretti, Gianluigi
    Vidiri, Antonello
    Gasparro, Simona
    Cognetti, Francesco
    Pellegrini, Domenica
    Fabi, Alessandra
    IN VIVO, 2018, 32 (04): : 839 - 842
  • [2] Long-term tolerance and cardiac function in breast cancer patients receiving trastuzumab therapy
    Huang, Ping
    Dai, Shujun
    Ye, Zhimin
    Liu, Yajuan
    Chen, Zhanhong
    Zheng, Yabing
    Shao, Xiying
    Lei, Lei
    Wang, Xiaojia
    ONCOTARGET, 2017, 8 (02) : 2069 - 2075
  • [3] Pertuzumab/Trastuzumab Breast Cancer Therapy Is Associated With Complex Hemodynamic Abnormalities
    Koneru, Srikanth
    Sato, Kimi
    Goldberg, Adam
    Sanghi, Vedha
    Montero, Alberto
    Grimm, Richard A.
    Rodriguez, L. Leonardo
    Griffin, Brian P.
    Budd, G. Thomas
    Collier, Patrick C.
    Tamarappoo, Balaji
    Desai, Milind Y.
    Popovic, Zoran B.
    JACC-CARDIOVASCULAR IMAGING, 2018, 11 (08) : 1206 - 1207
  • [4] Cardiovascular sequelae of trastuzumab and anthracycline in long-term survivors of breast cancer
    Glen, Claire
    Morrow, Andrew
    Roditi, Giles
    Hopkins, Tracey
    Macpherson, Iain
    Stewart, Philip
    Petrie, Mark C.
    Berry, Colin
    Epstein, Fred
    Lang, Ninian N.
    Mangion, Kenneth
    HEART, 2024, 110 (09) : 650 - 656
  • [5] Long-term results of breast conservation therapy for breast cancer
    Neff, PT
    Bear, HD
    Pierce, CV
    Grimes, MM
    Fleming, MD
    Neifeld, JP
    Arthur, D
    Horsley, JS
    Lawrence, W
    Kornstein, MJ
    ANNALS OF SURGERY, 1996, 223 (06) : 709 - 716
  • [6] Predictors of Long-Term Disease Control and Survival for HER2-Positive Advanced Breast Cancer Patients Treated With Pertuzumab, Trastuzumab, and Docetaxel
    Hopkins, Ashley M.
    Rowland, Andrew
    McKinnon, Ross A.
    Sorich, Michael J.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [7] DEVELOPMENT OF BREAST-CANCER DURING LONG-TERM TAMOXIFEN THERAPY FOR LYMPHANGIOLEIOMYOMATOSIS
    MILLWARD, MJ
    CANTWELL, BMJ
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (06) : 806 - 806
  • [8] Long-Term Survivor with Intrathecal and Intravenous Trastuzumab Treatment in Metastatic Breast Cancer
    Pluchart, H.
    Jacquet, E.
    Charlety, D.
    Allenet, B.
    Bedouch, P.
    Mousseau, M.
    TARGETED ONCOLOGY, 2016, 11 (05) : 687 - 691
  • [9] Pertuzumab plus Trastuzumab in Metastatic Breast Cancer REPLY
    Baselga, Jose
    Benyunes, Mark C.
    Swain, Sandra M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (14): : 1349 - 1350
  • [10] Long-Term Survivor with Intrathecal and Intravenous Trastuzumab Treatment in Metastatic Breast Cancer
    H. Pluchart
    E. Jacquet
    D. Charlety
    B. Allenet
    P. Bedouch
    M. Mousseau
    Targeted Oncology, 2016, 11 : 687 - 691
12345